Topic: Why see a uveal melanoma oncologist and how to talk with your oncologist about clinical trials?
A Cure in Sight is joined by Dr. Justin Moser, a medical oncologist in the Phoenix, Arizona area.
He shares helpful tips to keep in mind when having discussions with a medical oncologist, and why it’s vital for patients to be seen and under the watch and care of a medical oncologist either familiar with uveal melanoma protocols for scans and care, or someone who is willing to learn from another oncologist in the field.
Dr. Moser explains some of the process behind selecting a clinical trial for a patient experiencing metastatic spread, and how you as a patient can ask for less known trials that are not entirely ready for Uveal melanoma yet, but are planned to have a few spots for uveal melanoma spread.
Thank you Dr. Moser for your time and research!
Dr. Justin Moser is a medical oncologist and hematologist and associate clinical investigator at HonorHealth Research Institute, clinical assistant professor at the University of Arizona College of Medicine – Phoenix, and an adjunct faculty member at the Translational Genomics Research Institute (TGen). He is an expert in the treatment of melanoma and other skin cancers and co-leads the Cutaneous Oncology Tumor Site Strategy Group for HonorHealth.
Dr. Moser graduated from the University of Iowa Carver College of Medicine with distinctions in research and teaching. He completed his Internal Medicine Residency at Mayo Clinic in Rochester, Minnesota and his fellowship in Hematology/Oncology at the Huntsman Cancer Institute. He has strong passion for developing new treatments for patients with cancer and was a visiting fellow at the Cancer Therapy Evaluation Program at the National Cancer Institute.
Dr. Moser’s has a special focus on patients with rare skin cancers, such as uveal melanoma, squamous cell carcinoma, Merkle cell carcinoma and basal cell carcinoma, as patients with these cancers often have fewer treatment options available.
For more information on the HonorHealth Research Institute Melanoma and Skin Cancer Clinic or to make an appointment please call our Nurse Navigators at 480-323-1364 or email clinicaltrials@honorhealth.com.
Be sure to follow us on Instagram @acureinsight, for more stories, tips, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINK TO PAYPAL OR VENMO
This podcast was hosted by Danet Peterson and produced by Agora Media.
E81 Q3 Webinar: The History and Future of OM with Dr. Harbour & Dr. Correa
E80: Worrying didn’t work: An OM Story, Guest Ellie Levine
E79: Special Research Call Out for OM patients, Guest Jennifer Stephens
Eye on Research - Key MUM Drugs & ARVO Updates w/ Dr. McKean, Dr. Moser, & Dr. Dalvin
EYE ON RESEARCH -Trials of Interest w/ Dr. Hamid and Dr. Carvajal
EYE ON RESEARCH 2023 - PERIO - 01 Update with Dr. Katz
E78: Biopsies & Prognostic Testing of the Eye, Guest Dr. Basil K. Williams
E77: Newsworthy Notes from ASCO 2023
E76: Will we SEE YOU in Seattle in September 2023?!
E75: Queer in Sight: PRIDE Month Perspectives
E74: Eye Just Turned 2 - A Story of Resilience in Cancer, Guest, Dean Weitenhagen
E73: Choosing Integrative Oncology - Patient Panel
E72: What is Integrative Oncology? Guest, Dr. Dan Rubin
E71: What is an ocularist? Guest, Starla Allen
E70: Navigating Clinical Trials 101, Guests, Kelly Goddard & Shahnaz Singh
E69: Mexico’s Eye Cancer Institute, with founder. Dr. David Ancona
E68: News From AACR 2023
E67: Who is Immunocore? Guest, Dr. Dar
E66: Protecting Your Mental Health, Guest, Dr. Sanger
E65: Pros & Cons of Radiation to the Eye, Guest, Dr. Basil K. Williams
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive